According to a research report titled ‘Global Hormone Replacement Therapy Market 2021-2028’, available with Market Study Report, global hormone replacement therapy market is projected to register 7.75% CAGR over the forecast period 2021-2028.
 

Increasing incidence of hormonal disorders, rising awareness about health problems associated with menopause, and innovation & launch of new products by prominent players are the major factors driving worldwide hormone replacement therapy market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3855553/
 

Moreover, availability of alternative therapy and launch of telemedicine clinical practice associations will create unique opportunities for industry development over the estimated period.
 

Despite the positive industry outlook, adverse reactions to prescribed medications coupled with high costs of hormone therapy due to customized treatment plans, high-quality medications, and follow-up appointments are restricting business development.
 

Based on therapy type, global hormone replacement therapy industry is arrayed into, human growth hormone, estrogen, thyroid, testosterone, and progestogen hormone replacement therapies.
 

Moving on to disease type, the market sphere is split into male hypogonadism, hypothyroidism, menopause, growth hormone deficiency, and others.
 

Elaborating on the route of administration, global hormone replacement therapy market comprises parenteral, transdermal, oral, and other routes of administration.
 

On the regional front, the research literature covers North America, Latin America, Asia-Pacific, Europe, and the Middle East and Africa. Expert analysts cite that Asia-Pacific hormone replacement therapy market is projected to register a robust compound annual growth rate over the forecast period. This can be attributed to increasing awareness about hormone replacement therapy, advancements in healthcare services focused on menopausal and hormonal imbalance disorders, and booming geriatric populace.
 

Key players in global hormone replacement therapy market space are Viatris Inc., Teva Pharmaceutical Industries Ltd., Pfizer Inc., Novo Nordisk A/S, Noven Pharmaceuticals Inc., Novartis International AG, Merck KGaA, Ipsen S.A., Genentech Inc., Eli Lilly & Company, Dr. Reddy’s Laboratories Ltd., Bayer AG, ANI Pharmaceuticals Inc., Amgen Inc., and Abbott Laboratories.